Published in Dig Dis Sci on May 30, 2013
Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. World J Gastroenterol (2014) 1.05
The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease. Med Devices (Auckl) (2014) 0.87
Critical comparison of elastography methods to assess chronic liver disease. Nat Rev Gastroenterol Hepatol (2016) 0.85
Spatially heterogeneous corneal mechanical responses before and after riboflavin-ultraviolet-A crosslinking. J Cataract Refract Surg (2014) 0.84
Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography. Am J Gastroenterol (2015) 0.82
Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature. Risk Manag Healthc Policy (2015) 0.76
Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis. Ont Health Technol Assess Ser (2015) 0.76
Management of hepatocellular carcinoma. Hepatology (2005) 27.42
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med (2011) 19.01
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol (2012) 16.93
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology (1996) 12.47
Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med (2011) 12.09
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology (2005) 9.44
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol (2002) 8.21
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology (2008) 6.15
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg (2006) 5.65
Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med (1995) 5.55
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology (1997) 5.53
Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology (2008) 5.07
Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol (2008) 4.21
Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol (2004) 4.12
Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology (2011) 3.70
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. J Hepatol (2001) 3.64
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology (2008) 3.47
Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. JAMA (2003) 3.25
Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology (1998) 3.00
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut (2003) 2.96
Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology (2001) 2.90
Hepatitis C and hepatocellular carcinoma. Hepatology (1997) 2.83
Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology (1995) 2.63
Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol (2010) 2.57
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol (2010) 2.50
Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Med Decis Making (2012) 2.21
The long-term pathological evolution of chronic hepatitis C. Hepatology (1996) 2.15
Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C. Ann Intern Med (1997) 2.09
A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology (2011) 2.08
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver Int (2010) 1.81
Liver transplantation for hepatocellular carcinoma. Semin Liver Dis (1999) 1.78
Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer (2005) 1.51
Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics (2009) 1.48
Retracted Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. J Cell Physiol (2006) 1.46
Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology (1994) 1.37
A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol (2010) 1.34
Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies. J Hepatol (2011) 1.30
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut (2002) 1.29
Empirically calibrated model of hepatitis C virus infection in the United States. Am J Epidemiol (2002) 1.26
Reduced mortality rates following elective percutaneous liver biopsies. Gastroenterology (2010) 1.26
Management of chronic hepatitis C: clinical audit of biopsy based management algorithm. BMJ (1997) 1.24
Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol (2003) 1.23
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess (2007) 1.21
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol (2009) 1.18
Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation. Health Technol Assess (2007) 1.15
Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis? Am J Gastroenterol (2007) 1.14
Survival and cost-effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma. Liver Transpl (2010) 1.08
Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation. Health Technol Assess (2011) 1.08
Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol (2008) 1.06
Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients. PLoS One (2011) 0.98
Economic evaluation of sorafenib in unresectable hepatocellular carcinoma. J Gastroenterol Hepatol (2010) 0.98
Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment. J Clin Epidemiol (2006) 0.97
Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice. Int J Technol Assess Health Care (2009) 0.96
All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study. Liver Int (2011) 0.94
Is hepatitis C virus carcinogenic? Gastroenterology (2012) 0.93
Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Aliment Pharmacol Ther (2004) 0.93
Comparison of health-related quality of life preferences between physicians and cirrhotic patients: implications for cost-utility analyses in chronic liver disease. Dig Dis Sci (2004) 0.92
Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation. Clin Transplant (2011) 0.89
Structural frameworks and key model parameters in cost-effectiveness analyses for current and future treatments of chronic hepatitis C. Value Health (2011) 0.87
Sorafenib for the treatment of advanced hepatocellular carcinoma. Health Technol Assess (2010) 0.83
Risk factors and prevention of hepatocellular carcinoma in HCV infection. Dig Dis Sci (1996) 0.79
New genetic discoveries and treatment for hepatitis C. JAMA (2012) 0.78
Cost-effectiveness of screening for hepatocellular carcinoma among subjects at different levels of risk. J Eval Clin Pract (2010) 0.76
The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci U S A (1997) 3.23
Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J Hepatol (1991) 1.76
Molecular recognition of acute myeloid leukemia using aptamers. Leukemia (2009) 1.63
Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: a cost-effectiveness analysis. Aliment Pharmacol Ther (2007) 1.62
Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology. Bioorg Med Chem Lett (1999) 1.54
Mycoplasma infections and different human carcinomas. World J Gastroenterol (2001) 1.48
The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus (2010) 1.42
Limited recovery of meiotic spindles in living human oocytes after cooling-rewarming observed using polarized light microscopy. Hum Reprod (2001) 1.41
Secretory clusterin is upregulated in rats with pulmonary arterial hypertension induced by systemic-to-pulmonary shunts and exerts important roles in pulmonary artery smooth muscle cells. Acta Physiol (Oxf) (2014) 1.39
Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab (1998) 1.38
Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol Biomarkers Prev (1998) 1.34
Eponemycin analogues: syntheses and use as probes of angiogenesis. Bioorg Med Chem (1998) 1.34
Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803. Biochem Biophys Res Commun (2001) 1.27
Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases. Gastroenterology (1983) 1.26
Ethnic differences in mammographic densities. Int J Epidemiol (2001) 1.23
A case-control study of mammographic densities in Hawaii. Breast Cancer Res Treat (2000) 1.18
Developmental ability of human oocytes with or without birefringent spindles imaged by Polscope before insemination. Hum Reprod (2001) 1.12
Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study. Am J Transplant (2013) 1.11
Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatology (1991) 1.10
Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. J Perinatol (2013) 1.08
An investigation of soy intake and mammographic characteristics in Hawaii. Breast Cancer Res (2001) 1.06
Circulating lipid A antibodies despite absence of systemic endotoxemia in patients with Crohn's disease. Dig Dis Sci (1984) 1.04
Alcohol intake, body weight, and mortality in a multiethnic prospective cohort. Epidemiology (1998) 1.03
The spindle observation and its relationship with fertilization after intracytoplasmic sperm injection in living human oocytes. Fertil Steril (2001) 1.03
Hybridization of DNA targets to glass-tethered oligonucleotide probes. Mol Biotechnol (1995) 1.02
[On an apparatus for the safe and controlable filling of the abdominal cavity with gas for laparoscopy]. Klin Wochenschr (1966) 1.02
Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer. Eur J Cancer (2009) 1.02
Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome. Ann Oncol (2006) 1.01
Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation. Cell Death Dis (2013) 0.99
Pancreatic cystic lesions: clinical predictors of malignancy in patients undergoing surgery. Aliment Pharmacol Ther (2009) 0.99
Advances in genosensor research. Clin Chem (1995) 0.97
CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation (2001) 0.93
Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis. Hepatology (1988) 0.93
Dynamic storage of dopamine in rat brain synaptic vesicles in vitro. J Neurochem (1995) 0.92
Cutting edge: membrane lymphotoxin regulates CD8(+) T cell-mediated intestinal allograft rejection. J Immunol (2001) 0.92
Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion. Heart (2005) 0.92
Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells. Cell Death Differ (2010) 0.92
[Significance of immunoglobulins for the diagnosis and evaluation of the course of liver diseases]. Klin Wochenschr (1969) 0.90
Immune response of peripheral blood mononuclear cells to HBx-antigen of hepatitis B virus. Hepatology (1991) 0.89
Exploring the feasibility and effects of a high-fruit and -vegetable diet in healthy women. Cancer Epidemiol Biomarkers Prev (1999) 0.89
Amphetamine releases dopamine from synaptic vesicles by dual mechanisms. Neurosci Lett (1996) 0.88
Mammography screening and the increase in breast cancer incidence in Hawaii. Cancer Epidemiol Biomarkers Prev (1997) 0.88
Diagnostic accuracy of CT in circumscript liver disease. AJR Am J Roentgenol (1978) 0.88
Anuric renal failure due to encasement of the ureters by lymphoma--ureteric obstruction without dilatation. Aust N Z J Med (1981) 0.87
From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease. Immunol Rev (1992) 0.87
In vitro maturation of human preovulatory oocytes reconstructed by germinal vesicle transfer. Fertil Steril (1999) 0.87
[Preparation of monoclonal antibodies to human vascular endothelial growth factor(VEGF121) and identification of its expression on gastric carcinoma cell line MGC803]. Zhonghua Zhong Liu Za Zhi (1999) 0.86
Antisense TGF-beta2 immunotherapy for hepatocellular carcinoma: treatment in a rat tumor model. Ann Surg Oncol (2001) 0.86
T lymphocytes from patients with primary biliary cirrhosis produce reduced amounts of lymphotoxin, tumor necrosis factor and interferon-gamma upon mitogen stimulation. J Hepatol (1992) 0.85
Determinants of mammographic densities among women of Asian, Native Hawaiian, and Caucasian ancestry. Ethn Dis (2001) 0.85
Sclerotherapy of a bleeding duodenal varix. Endoscopy (1982) 0.84
Herbs of the genus Phyllanthus in the treatment of chronic hepatitis B: observations with three preparations from different geographic sites. J Lab Clin Med (1995) 0.84
[Serum bilirubin determination in newborn infants. A new micromethod for the determination of serum of plasma bilirubin in newborn infants]. Fortschr Med (1975) 0.84
Risk of virus transmission by jet injection. Lancet (1988) 0.83
Computerized tomography and nuclear imaging of the liver: a comparative study in 83 cases. Eur J Nucl Med (1978) 0.82
Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection. J Med Virol (1985) 0.81
[Serum immunoglobulin concentrations in Crohn's disease. Clinical relevance and comparison with lipid-A-antibody titers (author's transl)]. Z Gastroenterol (1981) 0.81
[Ethanol influence on purine catabolism of human liver]. Verh Dtsch Ges Inn Med (1973) 0.81
Interferon alpha in hepatitis type B and non-A, non-B. Defective production by peripheral blood mononuclear cells in chronic infection and development of serum interferon in acute disease. J Hepatol (1988) 0.81
Inhibition of perioperative platelet aggregation using toradol (ketorolac). Ann Plast Surg (1993) 0.81
Prevalence of antibody to human herpesvirus 6 among blood donors infected with HIV. Lancet (1988) 0.81
Beta- and gamma-interferon in chronic active hepatitis B. A pilot trial of short-term combination therapy. Gastroenterology (1989) 0.81
Pulsed radiofrequency treatment for idiopathic trigeminal neuralgia: a retrospective analysis of the causes for ineffective pain relief. Eur J Pain (2013) 0.81
Influences of gender and region on responses to 5-HT in the rat small intestine. Pharmacology (2004) 0.81
Overexpression of toll-like receptor 3 in spleen is associated with experimental arthritis in rats. Scand J Immunol (2012) 0.80
Evaluation of coagulase-negative staphylococcal isolates from serial nasopharyngeal cultures of premature infants. Diagn Microbiol Infect Dis (1990) 0.80
P-selectin knockout mice have improved outcomes with both warm ischemia and small bowel transplantation. Transplant Proc (2004) 0.80
Primary endometrial natural killer (NK)/T cell lymphoma: case report and review of literature. Eur J Gynaecol Oncol (2012) 0.80
Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine. Eur J Clin Pharmacol (1984) 0.80
[The irritable colon syndrome. New therapeutic possibilities in the treatment of a frequent syndrome]. Fortschr Med (1978) 0.80
Two-fold elevation of expression of FoxM1 transcription factor in mouse embryonic fibroblasts enhances cell cycle checkpoint activity by stimulating p21 and Chk1 transcription. Cell Prolif (2010) 0.80
Retrograde colonic spread of sulphasalazine enemas. Scand J Gastroenterol (1982) 0.79
The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M. Cell Growth Differ (1999) 0.79
Influence of host size variation on the development of a koinobiont aphid parasitoid, Lysiphlebus ambiguus Haliday (Braconidae, Hymenoptera). Bull Entomol Res (2008) 0.79
Nuclear transfer in the rhesus monkey: practical and basic implications. Biol Reprod (1999) 0.79
Cytolytic T cell clones derived from liver tissue of patients with chronic hepatitis B. Eur J Immunol (1986) 0.79
A systematic comparison between collagen-induced arthritis and pristane-induced arthritis in Dark Agouti rats. Clin Exp Rheumatol (2010) 0.79
Detection of group B streptococci by agglutination testing from selective broth cultures. Ann Clin Lab Sci (1985) 0.79
[Studies on the metabolism of testosterone and delta-4-androstendione in the human liver]. Klin Wochenschr (1971) 0.79
Impact of stepwise hyperventilation on cerebral tissue oxygen saturation in anesthetized patients: a mechanistic study. Acta Anaesthesiol Scand (2013) 0.79
Cloning, characterization, and expression analysis of a CC chemokine gene from turbot (Scophthalmus maximus). Fish Physiol Biochem (2008) 0.79
Biological control of anthracnose (Colletotrichum gloeosporioides) in yam by Streptomyces sp.MJM5763. J Appl Microbiol (2011) 0.78
Recent progress in mammalian cloning. J Assist Reprod Genet (1998) 0.78
Clonal analysis of liver-derived T cells of patients with primary biliary cirrhosis. Clin Exp Immunol (1989) 0.78
Increased frequency of CD8+ CD45R0+ memory T lymphocytes in acute hepatitis B virus infection. J Hepatol (1993) 0.78
Autologous transplantation of blood-derived stem/progenitor cells for ischaemic heart disease. Int J Clin Pract (2011) 0.78
Coagulation and prothrombotic state parameters: a clinical analysis during early pregnancy. Ir J Med Sci (2011) 0.78
Time point is important for effects of syngeneic bone marrow transplantation for type 1 diabetes in mice. Transplant Proc (2009) 0.78
[Uric acid production in the human liver during parenteral fructose administration]. Verh Dtsch Ges Inn Med (1974) 0.78
The major plant-derived cannabinoid Δ(9)-tetrahydrocannabinol promotes hypertrophy and macrophage infiltration in adipose tissue. Horm Metab Res (2011) 0.78
Oxidation of glycosphingolipids under basic conditions: synthesis of glycosyl "serine acids" as opposed to "ceramide acids". Precursors for neoglycoconjugates with increased ligand binding affinity. Biochemistry (1999) 0.78
Effects of epidermal growth factor and follicle-stimulating hormone during in vitro maturation on cytoplasmic maturation of porcine oocytes. Mol Reprod Dev (1997) 0.78
Synergistic anti-tumor effect of ultrasound and hematoporphyrin on sarcoma180 cells with special reference to the changes of morphology and cytochrome oxidase activity of tumor cells. J Exp Clin Cancer Res (2004) 0.78
Mouse-rabbit germinal vesicle transfer reveals that factors regulating oocyte meiotic progression are not species-specific in mammals. J Exp Zool (2001) 0.78
Cloning, molecular characterization and expression analysis of heat shock cognate 70 (Hsc70) cDNA from turbot (Scophthalmus maximus). Fish Physiol Biochem (2013) 0.77
Allelic variation in the TNF-beta gene does not explain the low TNF-beta response in patients with primary biliary cirrhosis. Scand J Immunol (1991) 0.77
Relationship of maternal to neonatal colonization with coagulase-negative staphylococci. Am J Perinatol (1990) 0.77
The risk of transmission of hepatitis B virus using jet injection in inoculation. J Infect Dis (1981) 0.77
Interferon-gamma +874A/T polymorphism is associated with asthma risk: a meta-analysis. J Investig Allergol Clin Immunol (2014) 0.77
Suppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3. Gene Ther (2013) 0.77